Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis

M. W. Schuster, E. Anaissie, D. Hurd, W. Bensinger, J. Mason, J. McCarty, R. Rifkin, R. Maziarz, Y. Halvorsen, V. Annino, W. Hahne

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis'. Together they form a unique fingerprint.